STEVENS CAPITAL MANAGEMENT LP - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 847 filers reported holding NOVARTIS A G in Q2 2014. The put-call ratio across all filers is 0.65 and the average weighting 0.6%.

Quarter-by-quarter ownership
STEVENS CAPITAL MANAGEMENT LP ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2020$374,000
+86.1%
4,298
+102.5%
0.14%
+631.6%
Q4 2019$201,000
-70.1%
2,122
-72.6%
0.02%
-68.9%
Q3 2019$672,000
-19.4%
7,731
-15.4%
0.06%
+64.9%
Q2 2019$834,000
+69.5%
9,137
+60.1%
0.04%
+105.6%
Q3 2018$492,000
-64.1%
5,708
-68.5%
0.02%
-63.3%
Q2 2018$1,369,000
+18.4%
18,122
+26.8%
0.05%
+11.4%
Q1 2018$1,156,000
-10.5%
14,294
-7.0%
0.04%
-12.0%
Q4 2017$1,291,000
+191.4%
15,378
+197.9%
0.05%
+212.5%
Q3 2017$443,000
-48.4%
5,162
-55.3%
0.02%
-51.5%
Q1 2017$858,000
-16.2%
11,557
-18.2%
0.03%
-17.5%
Q1 2016$1,024,000
-42.7%
14,135
-32.0%
0.04%
-42.9%
Q4 2015$1,788,000
+130.4%
20,782
+146.2%
0.07%
+94.4%
Q3 2015$776,000
-82.3%
8,442
-81.1%
0.04%
-77.2%
Q2 2015$4,386,000
-14.7%
44,599
-14.4%
0.16%
-13.7%
Q1 2015$5,140,000
+101.1%
52,124
+89.0%
0.18%
+112.8%
Q4 2014$2,556,000
-29.8%
27,586
-28.7%
0.09%
-21.8%
Q3 2014$3,640,000
-24.5%
38,666
-27.4%
0.11%
-14.7%
Q2 2014$4,822,000
+685.3%
53,267
+637.2%
0.13%
+658.8%
Q1 2014$614,000
-73.1%
7,226
-74.6%
0.02%
-74.6%
Q4 2013$2,285,000
+34.1%
28,427
+28.0%
0.07%
+34.0%
Q3 2013$1,704,000
-42.8%
22,208
-47.3%
0.05%
-49.5%
Q2 2013$2,981,00042,1550.10%
Other shareholders
NOVARTIS A G shareholders Q2 2014
NameSharesValueWeighting ↓
PRENTISS SMITH & CO INC 146,405$11,768,0006.16%
MANAGED ASSET PORTFOLIOS, LLC 104,290$8,383,0005.88%
St. James Investment Company, LLC 645,032$51,848,0005.72%
NORTHROAD CAPITAL MANAGEMENT LLC 160,469$12,898,0004.62%
BROWN BROTHERS HARRIMAN & CO 12,336,767$991,629,0004.48%
Osher Van de Voorde Investment Management 83,754$6,732,0004.35%
SCHARF INVESTMENTS, LLC 1,185,951$95,327,0004.26%
Timber Creek Capital Management LLC 56,233$4,520,0004.22%
PROFESSIONAL ADVISORY SERVICES INC 200,030$16,078,0004.18%
Fayerweather Charles 14,565$1,171,0004.09%
View complete list of NOVARTIS A G shareholders